These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33689243)

  • 1. [Sjögren's syndrome: from diagnosis to treatment].
    Dumusc A; Ribi C
    Rev Med Suisse; 2021 Mar; 17(729):477-480. PubMed ID: 33689243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
    Bowman SJ; Fox R; Dörner T; Mariette X; Papas A; Grader-Beck T; Fisher BA; Barcelos F; De Vita S; Schulze-Koops H; Moots RJ; Junge G; Woznicki JN; Sopala MA; Luo WL; Hueber W
    Lancet; 2022 Jan; 399(10320):161-171. PubMed ID: 34861168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
    Fisher BA; Mariette X; Papas A; Grader-Beck T; Bootsma H; Ng WF; van Daele PLA; Finzel S; Noaiseh G; Elgueta S; Hermann J; McCoy SS; Akpek E; Bookman A; Sopala M; Montecchi-Palmer M; Luo WL; Scheurer C; Hueber W;
    Lancet; 2024 Aug; 404(10452):540-553. PubMed ID: 39096929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.
    Billings M; Amin Hadavand M; Alevizos I
    Oral Dis; 2018 Mar; 24(1-2):184-190. PubMed ID: 29480635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.
    Tsuboi H; Hagiwara S; Asashima H; Takahashi H; Hirota T; Noma H; Umehara H; Kawakami A; Nakamura H; Sano H; Tsubota K; Ogawa Y; Takamura E; Saito I; Inoue H; Nakamura S; Moriyama M; Takeuchi T; Tanaka Y; Hirata S; Mimori T; Matsumoto I; Sumida T
    Ann Rheum Dis; 2017 Dec; 76(12):1980-1985. PubMed ID: 28330998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Shiboski CH; Shiboski SC; Seror R; Criswell LA; Labetoulle M; Lietman TM; Rasmussen A; Scofield H; Vitali C; Bowman SJ; Mariette X;
    Ann Rheum Dis; 2017 Jan; 76(1):9-16. PubMed ID: 27789466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.
    Shiboski CH; Shiboski SC; Seror R; Criswell LA; Labetoulle M; Lietman TM; Rasmussen A; Scofield H; Vitali C; Bowman SJ; Mariette X;
    Arthritis Rheumatol; 2017 Jan; 69(1):35-45. PubMed ID: 27785888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
    Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjogren's syndrome.
    Choudhry HS; Hosseini S; Choudhry HS; Fatahzadeh M; Khianey R; Dastjerdi MH
    Ocul Surf; 2022 Oct; 26():75-87. PubMed ID: 35961534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of dry eye in patients with pre-existing Sjögren's syndrome according to the revised 2016 ACR-EULAR classification criteria.
    Yoon HJ; Choi W; Yang JM; Ji YS; Lee SS; Yoon KC
    Medicine (Baltimore); 2019 Mar; 98(9):e14641. PubMed ID: 30817584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome: data from a nationwide cohort for Sjögren's syndrome in Korea.
    Park Y; Lee J; Koh JH; Sung YK; Lee SS; Choe JY; Shim SC; Kim JM; Kwon SR; Kim HO; Chung SH; Park SH; Kwok SK
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):107-113. PubMed ID: 31376264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
    Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK
    J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contemporary diagnostics of the primary Sjögren's syndrome].
    Parada-Turska J
    Wiad Lek; 2016; 69(4):680-685. PubMed ID: 27941210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sjögren Syndrome : the ENT specialist contributes to the workup].
    Breitenstein A; Brülhart L; Jaquet Y
    Rev Med Suisse; 2020 Oct; 16(709):1860-1864. PubMed ID: 33026728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures for primary Sjögren's syndrome.
    Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Ramos-Casals M; Ravaud P; Theander E; Tzioufas A; Vitali C
    J Autoimmun; 2012 Aug; 39(1-2):97-102. PubMed ID: 22365784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
    Oni C; Mitchell S; James K; Ng WF; Griffiths B; Hindmarsh V; Price E; Pease CT; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman SJ;
    Rheumatology (Oxford); 2016 Mar; 55(3):544-52. PubMed ID: 26510429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
    Ogawa Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic Pain in the Eyes, Body, and Mouth: Insights from the Sjögren's International Collaborative Clinical Alliance.
    Gebreegziabher EA; Bunya VY; Baer AN; Jordan RC; Akpek EK; Rose-Nussbaumer J; Criswell LA; Shiboski CH; Lietman TM; Gonzales JA
    Pain Pract; 2021 Jul; 21(6):630-637. PubMed ID: 33527744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
    Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.